Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VIVO Cannabis Inc. V.PDA


Primary Symbol: VVCIF

Healthcare Drug Manufacturers - Specialty & Generic
VIVO Cannabis Inc is a Canada-based company. It is involved in the production and sale of medical and recreational cannabis and the provision of cannabis-related medical information and services in Canada. The company's operating segment includes Cannabis, Patient Clinics, and Corporate. It generates maximum revenue from the Cannabis segment. The company has a presence across three geographical locations - Canada, Germany, and Australia.


OTCQB:VVCIF - Post by User

VIVO Cannabis Inc. > So what are we waiting for????
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(37)
•••
Comment by couveron Sep 01, 2020 12:20pm
305 Views
Post# 31486837

RE:So what are we waiting for????

RE:So what are we waiting for????waiting for debt issue resolution, if it's favorable or not.....

The analyst thinks the company’s cash on hand (approx. $22.2 million at the end of Q2) plus an assumed credit facility of $20 million will be more than sufficient to cover both the remaining $27.1-million of well-out-of-the-money convertible debentures set to mature on December 21, 2020, working capital expenses until the company achieves positive free cash flow.


<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities